Multicenter, Randomized, Controlled Study to Evaluate the Efficacy of Thymosin alpha1 in Patients With Severe Sepsis.

Trial Profile

Multicenter, Randomized, Controlled Study to Evaluate the Efficacy of Thymosin alpha1 in Patients With Severe Sepsis.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Jun 2011

At a glance

  • Drugs Thymalfasin (Primary)
  • Indications Sepsis
  • Focus Therapeutic Use
  • Acronyms ETASS
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Jul 2010 Planned end date changed from 1 Jan 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top